ROZEMA; David B.
Patent Applications and Registrations
Patent applications and USPTO patent grants for ROZEMA; David B..The latest application filed is for "rnai agents for hepatitis b virus infection".
Company Profile
16.75.102
- ROZEMA; David B. - Cross Plains WI
- Rozema; David B. - Madison WI
- Rozema; David B - Middleton WI
- Rozema; David B. - Middleton WI
Patent Activity
| Patent | Date |
|---|---|
| Rnai Agents For Hepatitis B Virus Infection App 20220079973 - LI; Zhen ; et al. | 2022-03-17 |
| Post-transcriptionally chemically modified double strand RNAs Grant 11,174,480 - Arhancet , et al. November 16, 2 | 2021-11-16 |
| Targeting Ligands For Therapeutic Compounds App 20210189394 - Rozema; David B ; et al. | 2021-06-24 |
| Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20210180066 - Wong; So ; et al. | 2021-06-17 |
| Rnai Agents For Hepatitis B Virus Infection App 20210100829 - LI; Zhen ; et al. | 2021-04-08 |
| Rnai Therapy For Hepatitis B Virus Infection App 20210052624 - WOODDELL; Christine I. ; et al. | 2021-02-25 |
| Compositions and methods for inhibiting gene expression of Hif2alpha Grant 10,927,373 - Wong , et al. February 23, 2 | 2021-02-23 |
| RNAi therapy for hepatitis B virus infection Grant 10,806,750 - Wooddell , et al. October 20, 2 | 2020-10-20 |
| RNAi agents for Hepatitis B virus infection Grant 10,780,108 - Li , et al. Sept | 2020-09-22 |
| Compositions And Methods For Inhibiting Gene Expression Of Lpa App 20200263179 - MELQUIST; Stacey ; et al. | 2020-08-20 |
| Compositions and methods for inhibiting gene expression of LPA Grant 10,662,427 - Melquist , et al. | 2020-05-26 |
| Post-transcriptionally chemically modified double strand RNAs Grant 10,640,769 - Arhancet , et al. | 2020-05-05 |
| RNAi Agents for Hepatitis B Virus Infection App 20190292547 - Li; Zhen ; et al. | 2019-09-26 |
| RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION App 20190255091 - Li; Zhen ; et al. | 2019-08-22 |
| Targeting Ligands For Therapeutic Compounds App 20190211333 - Rozema; David B. ; et al. | 2019-07-11 |
| Compositions for targeted delivery of siRNA Grant 10,316,316 - Lewis , et al. | 2019-06-11 |
| Targeting ligands for therapeutic compounds Grant 10,246,709 - Rozema , et al. | 2019-04-02 |
| Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo App 20190062748 - Rozema; David B. ; et al. | 2019-02-28 |
| Post-Transcriptionally Chemically Modified Double Strand RNAs App 20190048345 - Arhancet; Juan P. ; et al. | 2019-02-14 |
| Post-Transcriptionally Chemically Modified Double Strand RNAs App 20190040389 - Arhancet; Juan P. ; et al. | 2019-02-07 |
| RNAi Therapy for Hepatitis B Virus Infection App 20190022123 - Wooddell; Christine I. ; et al. | 2019-01-24 |
| RNAi Therapy for Hepatitis B Virus Infection Grant 10,130,651 - Wooddell , et al. November 20, 2 | 2018-11-20 |
| Post-transcriptionally chemically modified double strand RNAs Grant 10,131,911 - Arhancet , et al. November 20, 2 | 2018-11-20 |
| Disubstituted maleic anhydrides with altered kinetics of ring closure Grant 10,059,681 - Blokhin , et al. August 28, 2 | 2018-08-28 |
| Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20180230470 - Wong; So ; et al. | 2018-08-16 |
| Disulfide-containing alkyne linking agents Grant 10,047,361 - Almeida , et al. August 14, 2 | 2018-08-14 |
| Reversibly masked polymers Grant 10,022,456 - Rozema , et al. July 17, 2 | 2018-07-17 |
| Compositions and Methods for Inhibiting Gene Expression of LPA App 20180195070 - MELQUIST; Stacey ; et al. | 2018-07-12 |
| Compositions and methods for inhibiting gene expression of Hif2alpha Grant 9,976,141 - Wong , et al. May 22, 2 | 2018-05-22 |
| Small molecule conjugates for intracellular delivery of biologically active compounds Grant 9,968,647 - Hadwiger , et al. May 15, 2 | 2018-05-15 |
| POST-TRANSCRIPTIONALLY CHEMICALLY MODIFIED DOUBLE STRAND RNAs App 20180127753 - Arhancet; Juan P. ; et al. | 2018-05-10 |
| Compositions and methods for inhibiting gene expression of LPA Grant 9,932,586 - Melquist , et al. April 3, 2 | 2018-04-03 |
| Disulfide-Containing Alkyne Linking Agents App 20180023084 - Almeida; Aaron ; et al. | 2018-01-25 |
| Disulfide-containing alkyne linking agents Grant 9,803,201 - Almeida , et al. October 31, 2 | 2017-10-31 |
| Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA Grant 9,796,756 - Hadwiger , et al. October 24, 2 | 2017-10-24 |
| Targeting Ligands For Therapeutic Compounds App 20170253875 - Rozema; David B. ; et al. | 2017-09-07 |
| Compositions for Targeted Delivery of siRNA App 20170204408 - Lewis; David L ; et al. | 2017-07-20 |
| Compositions and Methods for Inhibiting Gene Expression of LPA App 20170096665 - Melquist; Stacey ; et al. | 2017-04-06 |
| Peptide-Based In Vivo siRNA Delivery System App 20170056472 - Rozema; David B. ; et al. | 2017-03-02 |
| RNAi Therapy for Hepatitis B Virus Infection App 20170035796 - Wooddell; Christine I. ; et al. | 2017-02-09 |
| Small Molecule Conjugates For Intracellular Delivery Of Biologically Active Compounds App 20170022505 - Hadwiger; Philipp ; et al. | 2017-01-26 |
| Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo App 20170022497 - Rozema; David B. ; et al. | 2017-01-26 |
| Peptide-based in vivo siRNA delivery system Grant 9,526,796 - Rozema , et al. December 27, 2 | 2016-12-27 |
| Compositions and Methods for Inhibiting Gene Expression of Hif2alpha App 20160348107 - Wong; So ; et al. | 2016-12-01 |
| Polyconjugates for delivery of RNAi triggers to tumor cells in vivo Grant 9,487,556 - Cheng , et al. November 8, 2 | 2016-11-08 |
| Disubstituted maleic anhydrides with altered kinetics of ring closure Grant 9,481,661 - Blokhin , et al. November 1, 2 | 2016-11-01 |
| Poly(acrylate) polymers for in vivo nucleic acid delivery Grant 9,452,221 - Wakefield , et al. September 27, 2 | 2016-09-27 |
| Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure App 20160272605 - Blokhin; Andrei V. ; et al. | 2016-09-22 |
| RNA Interference Agents App 20160272970 - Rozema; David B. ; et al. | 2016-09-22 |
| Disulfide-Containing Alkyne Linking Agents App 20160272971 - Almeida; Aaron ; et al. | 2016-09-22 |
| Compositions for Targeted Delivery of siRNA App 20160222384 - Lewis; David L ; et al. | 2016-08-04 |
| Compositions for targeted delivery of siRNA Grant 9,345,775 - Lewis , et al. May 24, 2 | 2016-05-24 |
| Galactose Cluster-Pharmacokinetic Modulator Targeting Moiety for siRNA App 20160102120 - Hadwiger; Philipp ; et al. | 2016-04-14 |
| Small molecule conjugates for intracellular delivery of biologically active compounds Grant 9,301,990 - Hadwiger , et al. April 5, 2 | 2016-04-05 |
| Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA Grant 9,249,179 - Hadwiger , et al. February 2, 2 | 2016-02-02 |
| Peptide-Based In Vivo siRNA Delivery System App 20150352221 - Rozema; David B ; et al. | 2015-12-10 |
| Small molecule conjugates for intracellular delivery of nucleic acids Grant 9,198,947 - Hadwiger , et al. December 1, 2 | 2015-12-01 |
| Reversibly Masked Polymers App 20150273081 - Rozema; David B ; et al. | 2015-10-01 |
| Peptide-based in vivo siRNA delivery system Grant 9,107,957 - Rozema , et al. August 18, 2 | 2015-08-18 |
| Compositions for Targeted Delivery of siRNA App 20150202298 - Lewis; David L. ; et al. | 2015-07-23 |
| Compositions for targeted delivery of siRNA Grant 9,011,919 - Rozema , et al. April 21, 2 | 2015-04-21 |
| Poly(acrylate) Polymers for In Vivo Nucleic Acid Delivery App 20150104408 - Wakefield; Darren H. ; et al. | 2015-04-16 |
| Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo App 20150045573 - Cheng; Weijun ; et al. | 2015-02-12 |
| Poly(acrylate) polymers for in vivo nucleic acid delivery Grant 8,933,047 - Wakefield , et al. January 13, 2 | 2015-01-13 |
| In vivo polynucleotide delivery conjugates having enzyme sensitive linkages Grant 8,802,773 - Rozema , et al. August 12, 2 | 2014-08-12 |
| Small molecule conjugates for intracellular delivery of nucleic acids App 20140135380 - Hadwiger; Philipp ; et al. | 2014-05-15 |
| Small molecule conjugates for intracellular delivery of biologically active compounds App 20140135381 - Hadwiger; Philipp ; et al. | 2014-05-15 |
| Disubstituted Maleic Anhydrides with Altered Kinetics of Ring Closure App 20140128584 - Blokhin; Andrei V. ; et al. | 2014-05-08 |
| Polyconjugates for in vivo delivery of polynucleotides Grant 8,658,211 - Rozema , et al. February 25, 2 | 2014-02-25 |
| Poly(acrylate) Polymers for In Vivo Nucleic Acid Delivery App 20130317079 - Wakefield; Darren H. ; et al. | 2013-11-28 |
| Peptide-Based In Vivo siRNA Delivery System App 20130281658 - Rozema; David B ; et al. | 2013-10-24 |
| Compounds and methods for reversible modification of biologically active molecules Grant 8,541,548 - Rozema September 24, 2 | 2013-09-24 |
| Compositions for Targeted Delivery of siRNA App 20130245091 - Rozema; David B. ; et al. | 2013-09-19 |
| Peptide-based in vivo siRNA delivery system Grant 8,501,930 - Rozema , et al. August 6, 2 | 2013-08-06 |
| In vivo polynucleotide delivery conjugates having enzyme sensitive linkages Grant 8,426,554 - Rozema , et al. April 23, 2 | 2013-04-23 |
| Compositions for targeted delivery of siRNA Grant 8,313,772 - Rozema , et al. November 20, 2 | 2012-11-20 |
| Polyconjugates for In Vivo Delivery of Polynucleotides App 20120230938 - ROZEMA; David B. ; et al. | 2012-09-13 |
| Endosomolytic polymers Grant 8,217,015 - Rozema , et al. July 10, 2 | 2012-07-10 |
| In Vivo Polynucleotide Delivery Conjugates Having Enzyme Sensitive Linkages App 20120172412 - Rozema; David B. ; et al. | 2012-07-05 |
| Endosomolytic polymers Grant 8,211,468 - Rozema , et al. July 3, 2 | 2012-07-03 |
| Peptide-Based In Vivo siRNA Delivery System App 20120165393 - Rozema; David B. ; et al. | 2012-06-28 |
| GALACTOSE CLUSTER-PHARMACOKINETIC MODULATOR TARGETING MOIETY FOR siRNA App 20120157509 - Hadwiger; Philipp ; et al. | 2012-06-21 |
| Polyconjugates for in vivo delivery of polynucleotides Grant 8,137,695 - Rozema , et al. March 20, 2 | 2012-03-20 |
| Membrane active heteropolymers Grant 8,138,383 - Wakefield , et al. March 20, 2 | 2012-03-20 |
| Endosomolytic poly(acrylate) polymers Grant 8,017,109 - Wakefield , et al. September 13, 2 | 2011-09-13 |
| Endosomolytic poly(vinyl ether) polymers Grant 8,008,355 - Rozema , et al. August 30, 2 | 2011-08-30 |
| Compositions for Targeted Delivery of siRNA App 20110207799 - Rozema; David B. ; et al. | 2011-08-25 |
| Membrane active heteropolymers Grant 7,985,406 - Monahan , et al. July 26, 2 | 2011-07-26 |
| Membrane active polymers Grant 7,871,818 - Rozema , et al. January 18, 2 | 2011-01-18 |
| Reversible attachment of a membrane active polymer to a polynucleotide Grant 7,816,337 - Rozema , et al. October 19, 2 | 2010-10-19 |
| Polyvinylethers for delivery of polynucleotides to mammalian cells Grant 7,682,626 - Rozema , et al. March 23, 2 | 2010-03-23 |
| Membrane Active Heteropolymers App 20090048410 - Wakefield; Darren H. ; et al. | 2009-02-19 |
| Process of making a compound by forming a polymer from a template drug Grant 7,482,160 - Monahan , et al. January 27, 2 | 2009-01-27 |
| Membrane Active Heteropolymers App 20090023890 - Monahan; Sean D. ; et al. | 2009-01-22 |
| Formation of polyampholytes in the presence of a polyion Grant 7,470,539 - Wakefield , et al. December 30, 2 | 2008-12-30 |
| Endosomolytic Poly(Vinyl Ether) Polymers App 20080287628 - Rozema; David B. ; et al. | 2008-11-20 |
| Endosomolytic Poly(Acrylate) Polymers App 20080287630 - Wakefield; Darren H. ; et al. | 2008-11-20 |
| Endosomolytic Modified Poly(Alcohol) and Poly(Amine) Polymers App 20080281044 - Monahan; Sean D. ; et al. | 2008-11-13 |
| Reversibly Masked Polymers App 20080281041 - Rozema; David B. ; et al. | 2008-11-13 |
| Compounds and Methods for Reversible Modification of Biologically Active Molecules App 20080281074 - Rozema; David B. | 2008-11-13 |
| Endosomolytic Poly-Beta-Aminoester Polymers App 20080269450 - Wakefield; Darren H. ; et al. | 2008-10-30 |
| Reversible modification of amine-containing compounds Grant 7,442,764 - Rozema , et al. October 28, 2 | 2008-10-28 |
| Composition For In Vivo Delivery App 20080200661 - Rozema; David B. | 2008-08-21 |
| Polyconjugates for In Vivo Delivery of Polynucleotides App 20080152661 - Rozema; David B. ; et al. | 2008-06-26 |
| Labile Linkage for Compound Delivery to a Cell App 20080132689 - Rozema; David B. ; et al. | 2008-06-05 |
| Labile linkage for compound delivery to a cell Grant 7,348,453 - Rozema , et al. March 25, 2 | 2008-03-25 |
| Compound containing a labile disulfide bond App 20070191281 - Wolff; Jon A. ; et al. | 2007-08-16 |
| Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene App 20070173465 - Monahan; Sean D. ; et al. | 2007-07-26 |
| Compositions and methods for drug delivery using pH sensitive molecules Grant 7,208,314 - Monahan , et al. April 24, 2 | 2007-04-24 |
| Endosomolytic Polymers App 20070036865 - Rozema; David B. ; et al. | 2007-02-15 |
| Intravascular delivery of non-viral nucleic acid Grant 7,148,205 - Monahan , et al. December 12, 2 | 2006-12-12 |
| Compositions and methods for drug delivery using pH sensitive molecules Grant 7,138,382 - Wolff , et al. November 21, 2 | 2006-11-21 |
| Compositions and methods for drug delivery using pH sensitive molecules Grant 7,098,032 - Trubetskoy , et al. August 29, 2 | 2006-08-29 |
| Polyampholytes for delivering polyions to a cell Grant 7,098,030 - Rozema , et al. August 29, 2 | 2006-08-29 |
| Formation of polyampholytes in the presence of a polyion Grant 7,094,605 - Wakefield , et al. August 22, 2 | 2006-08-22 |
| Compound containing a labile disulfide bond Grant 7,087,770 - Wolff , et al. August 8, 2 | 2006-08-08 |
| Process of making a compound by forming a polymer from a template drug App 20060159764 - Monahan; Sean D. ; et al. | 2006-07-20 |
| Reversible modification of amine-containing compounds App 20060122096 - Rozema; David B. ; et al. | 2006-06-08 |
| pH-titratable polyampholytes for delivering polyions to a cell Grant 7,033,607 - Trubetskoy , et al. April 25, 2 | 2006-04-25 |
| Reversible modification of membrane interaction Grant 7,019,113 - Rozema , et al. March 28, 2 | 2006-03-28 |
| Formation of polyampholytes in the presence of a polyion App 20060063257 - Wakefield; Darren H. ; et al. | 2006-03-23 |
| Reversible modification of membrane interaction App 20050250683 - Rozema, David B. ; et al. | 2005-11-10 |
| Compound containing a labile disulfide bond Grant 6,936,729 - Wolff , et al. August 30, 2 | 2005-08-30 |
| Formation of polyampholytes in the presence of a polyion App 20050170505 - Wakefield, Darren H. ; et al. | 2005-08-04 |
| Compositions and methods for drug delivery using pH sensitive molecules Grant 6,919,091 - Trubetskoy , et al. July 19, 2 | 2005-07-19 |
| Intravascular delivery of non-viral nucleic acid App 20050153451 - Wolff, Jon A. ; et al. | 2005-07-14 |
| Compositions and methods for drug delivery using pH sensitive molecules App 20050123600 - Trubetskoy, Vladimir S. ; et al. | 2005-06-09 |
| Polynucleotide complex delivery Grant 6,897,068 - Monahan , et al. May 24, 2 | 2005-05-24 |
| Process for delivering nucleic acids to cardiac tissue Grant 6,867,196 - Wolff , et al. March 15, 2 | 2005-03-15 |
| Labile linkage for compound delivery to a cell App 20050054604 - Rozema, David B. ; et al. | 2005-03-10 |
| Polyampholytes for delivering polyions to a cell App 20050037496 - Rozema, David B. ; et al. | 2005-02-17 |
| Genetic vaccines for cancer therapy App 20050036995 - Herweijer, Hans ; et al. | 2005-02-17 |
| Compound containing a labile disulfide bond App 20050020518 - Wolff, Jon A. ; et al. | 2005-01-27 |
| Intravascular delivery of non-viral nucleic acid App 20040259828 - Wolff, Jon A. ; et al. | 2004-12-23 |
| Intravascular delivery of non-viral nucleic acid App 20040198678 - Monahan, Sean D. ; et al. | 2004-10-07 |
| Endosomolytic polymers App 20040198687 - Rozema, David B. ; et al. | 2004-10-07 |
| Delivery of siRNA to cells using polyampholytes App 20040162235 - Trubetskoy, Vladimir S. ; et al. | 2004-08-19 |
| Reversible attachment of a membrane active polymer to a polynucleotide App 20040162260 - Rozema, David B. ; et al. | 2004-08-19 |
| Polyvinylethers for delivery of polynucleotides to mammalian cells App 20040156909 - Rozema, David B. ; et al. | 2004-08-12 |
| Membrane active polymers App 20040151775 - Rozema, David B. ; et al. | 2004-08-05 |
| Compositions and methods for drug delivery using amphiphile binding molecules App 20040137625 - Wolff, Jon A. ; et al. | 2004-07-15 |
| Intravascular delivery of non-viral nucleic acid App 20040106567 - Hagstrom, James E. ; et al. | 2004-06-03 |
| Compositions and methods for drug delivery using amphiphile binding molecules Grant 6,740,643 - Wolff , et al. May 25, 2 | 2004-05-25 |
| Intravascular delivery of non-viral nucleic acid App 20040072785 - Wolff, Jon A. ; et al. | 2004-04-15 |
| Compositions and methods for drug delivery using pH sensitive molecules App 20040058446 - Wolff, Jon A. ; et al. | 2004-03-25 |
| Intravascular delivery of non-viral nucleic acid App 20040019007 - Monahan, Sean D. ; et al. | 2004-01-29 |
| Processes for inhibiting gene expression using polynucleotides App 20030228691 - Lewis, David L. ; et al. | 2003-12-11 |
| Compositions and processes for inhibiting gene expression using polynucleotides App 20030224055 - Lewis, David L. ; et al. | 2003-12-04 |
| Reversible modification of membrane interaction App 20030220264 - Rozema, David B. ; et al. | 2003-11-27 |
| Intravascular delivery of non-viral nucleic acid App 20030216347 - Monahan, Sean D. ; et al. | 2003-11-20 |
| Compositions and methods for drug delivery using pH sensitive molecules App 20030199090 - Monahan, Sean D. ; et al. | 2003-10-23 |
| Compositions and methods for drug delivery using pH sensitive molecules Grant 6,630,351 - Monahan , et al. October 7, 2 | 2003-10-07 |
| Intravascular delivery of non-viral nucleic acid Grant 6,627,616 - Monahan , et al. September 30, 2 | 2003-09-30 |
| Polynucleotide complex delivery App 20030166280 - Monahan, Sean D. ; et al. | 2003-09-04 |
| Expression of zeta negative and zeta positive nucleic acids using a dystrophin gene App 20030130224 - Monahan, Sean D. ; et al. | 2003-07-10 |
| Compositions and methods for drug delivery using pH sensitive molecules App 20030026841 - Trubetskoy, Vladimir S. ; et al. | 2003-02-06 |
| pH-titratable polyampholytes for delivering polyions to a cell App 20030008009 - Trubetskoy, Vladimir S. ; et al. | 2003-01-09 |
| Intravascular delivery of non-viral nucleic acid App 20020137707 - Monahan, Sean D. ; et al. | 2002-09-26 |
| Charge reversal of polyion complexes App 20020052335 - Rozema, David B. ; et al. | 2002-05-02 |
| Intravascular delivery of non-viral nucleic acid Grant 6,379,966 - Monahan , et al. April 30, 2 | 2002-04-30 |
| Compound containing a labile disulfide bond App 20010044417 - Wolff, Jon A. ; et al. | 2001-11-22 |
| Compositions and methods for drug delivery using amphiphile binding molecules App 20010044412 - Wolff, Jon A. ; et al. | 2001-11-22 |
| Compound containing a labile disulfide bond App 20010036926 - Wolff, Jon A. ; et al. | 2001-11-01 |
| Intravascular Delivery Of Non-viral Nucleic Acid App 20010019723 - MONAHAN, SEAN D. ; et al. | 2001-09-06 |
| Intravascular Delivery Of Non-viral Nucleic Acid App 20010004636 - MONAHAN, SEAN D. ; et al. | 2001-06-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 